You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-obesity Medications

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 2 Diabetes, Obesity Trial in Cleveland (Weight Management Program (WMP), Traditional care, Phentermine / Topiramate

Recruiting
  • Type 2 Diabetes
  • Obesity
  • Weight Management Program (WMP)
  • +5 more
  • Cleveland, Ohio
    Cleveland Clinic
Jan 28, 2022

Metabolic Side-effects of Anti-psychotic Medications -Nested

Active, not recruiting
  • Psychotic Disorders
  • Ramat Gan, Israel
    Sheba Medical Center, Psychiatry Department
May 23, 2023

Obesity Trial in Loma Linda (Semaglutide, Orlistat, Phentermine/Topiramate)

Recruiting
  • Obesity
  • Loma Linda, California
    Novo Nordisk Investigational Site
Jan 24, 2023

Dose Reduction and Discontinuation With Anti-Fibrotic

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Ridgefield, Connecticut
    Boehringer Ingelheim
Mar 24, 2023

Epilepsy, Epilepsy in Children Trial in Seoul

Recruiting
  • Epilepsy
  • Epilepsy in Children
    • Seoul, Korea, Republic of
      Asan Medical Center
    Feb 13, 2023

    Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Trial in Tempe (CCX168, Midazolam, Celecoxib)

    Completed
    • Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
    • Tempe, Arizona
      Celerion
    Aug 15, 2023

    Anti-obesity Pharmacotherapy and Inflammation

    Not yet recruiting
    • Obesity
    • Liraglutide or Semaglutide
    • Phentermine-Topiramate combination
    • New Orleans, Louisiana
    • +1 more
    Mar 3, 2023

    Nonalcoholic Fatty Liver, Osteoporosis, Postmenopausal Trial (Denosumab, Alendronate Sodium)

    Not yet recruiting
    • Nonalcoholic Fatty Liver
    • Osteoporosis, Postmenopausal
    • (no location specified)
    Aug 6, 2022

    Diabetes, Prostatic Hyperplasia Trial in Cairo (International prostate symptom score, Assessment of prostate volume, Pittsburgh

    Completed
    • Diabetes Mellitus
    • Prostatic Hyperplasia
    • International prostate symptom score
    • +3 more
    • Cairo, Egypt
    • +1 more
    Nov 19, 2023

    Acute Myeloid Leukemia Trial in Philadelphia (Text Message-Based Navigation Intervention, Behavioral, Psychological or

    Recruiting
    • Acute Myeloid Leukemia
    • Text Message-Based Navigation Intervention
    • +3 more
    • Philadelphia, Pennsylvania
    • +1 more
    Oct 25, 2022

    PSA Trial in Chicago (Ibuprofen 400 mg)

    Active, not recruiting
    • PSA
    • Ibuprofen 400 mg
    • Chicago, Illinois
      University of Chicago
    Aug 21, 2022

    Post-fracture Medication and Mortality

    Completed
    • Osteoporosis
    • +4 more
    • Anti-osteoporosis medications
    • Tainan, Taiwan
      Department of Family Medicine, National Cheng Kung Univ Hosp
    May 9, 2022

    Type1 Diabetes, Obesity Trial in Milan (Microbiome-targeted diet, Usual care diet)

    Recruiting
    • Type1 Diabetes
    • Obesity
    • Microbiome-targeted diet
    • Usual care diet
    • Milan, Milano, Italy
    • +1 more
    Mar 1, 2023

    Submental Fat Trial (RZL-012, RZL-012+Lidacaine injection prior treatment, RZL-012+Medrol)

    Not yet recruiting
    • Submental Fat
    • (no location specified)
    Jul 25, 2022

    Chronic Pain Trial in Redwood City (Anti-convulsant medications, Anti-depressant medications)

    Recruiting
    • Chronic Pain
    • Anti-convulsant medications
    • Anti-depressant medications
    • Redwood City, California
      Stanford Pain Management Center
    Mar 1, 2022

    Obesity, Adult Trial in Riyadh (Probiotic, Placebo)

    Active, not recruiting
    • Obesity
    • Adult
    • Riyadh, Saudi Arabia
      King Saud University
    Dec 24, 2022

    Pediatric Obesity Trial in Palo Alto (Topiramate, Phentermine)

    Withdrawn
    • Pediatric Obesity
    • Palo Alto, California
      Stanford University
    May 19, 2022

    Anti-hypertensive Medications on Diagnostic Accuracy in

    Recruiting
    • Hypertension
    • Primary Aldosteronism
    • withdraw antihypertensive drugs
    • Chongqing, Chongqing, China
    • +1 more
    Feb 17, 2022

    Epilepsy, Treatment Adherence Trial in Kilifi (Mobile phone message reminders.)

    Enrolling by invitation
    • Epilepsy
    • Treatment Adherence
    • Mobile phone message reminders.
    • Kilifi, Kenya
      KEMRI Wellcome Trust Research Programme
    Apr 4, 2022

    Body Composition Improvement With Visceral Adiposity-Focused

    Recruiting
    • Obesity
    • +3 more
    • 20Lighter Program
    • Little Rock, Arkansas
    • +1 more
    Dec 18, 2022

    Palliative Surgery Versus Additional Anti-Seizure Medications

    Not yet recruiting
    • Lennox Gastaut Syndrome
      • (no location specified)
      May 10, 2022

      Epilepsy, Pregnancy Related Trial in Pittsburgh (Lamotrigine, Levetiracetam)

      Recruiting
      • Epilepsy
      • Pregnancy Related
      • Pittsburgh, Pennsylvania
        Kaufmann Medical Building
      Jan 4, 2023

      Overweight and Obesity, Hypercholesterolemia, Hypertriglyceridemia Trial in Murcia (Silibinin A)

      Active, not recruiting
      • Overweight and Obesity
      • +2 more
      • Silibinin A
      • Murcia, Spain
        Faculty of Nursing. Catholic University of Murcia
      May 17, 2022

      Overweight and Obesity Trial in Lahore (Phaseolus Vulgaris, Placebo)

      Not yet recruiting
      • Overweight and Obesity
      • Phaseolus Vulgaris
      • Placebo
      • Lahore, Punjab, Pakistan
      • +1 more
      Jul 6, 2022

      Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Multiple Chronic Conditions Trial in Ann Arbor (Patient Reported Outcome

      Terminated
      • Chronic Myeloid Leukemia
      • +2 more
      • Patient Reported Outcome Measure (PROM)
      • +2 more
      • Ann Arbor, Michigan
        University of Michigan Rogel Cancer Center
      Nov 21, 2022